Azelastine, a common nasal spray for allergies, reduced the risk of COVID-19 and colds in one small trial. Larger studies are needed before recommending widespread use.

Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.

Those are some pretty impressive findings, and it’s not the only data to suggest that azelastine may help lower your risk of ...

Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...

Scientists believe that medication given through the nose has the potential to be more effective because it attacks or blocks ...

(CNN) — Amid the uncertainty surrounding eligibility for and access to the latest Covid-19 vaccine, a new study has found that a common nasal spray could help prevent infection. This randomized ...